Fresh Tracks EBITDA vs. Current Valuation

FRTXDelisted Stock  USD 0.78  0.09  10.34%   
Based on Fresh Tracks' profitability indicators, Fresh Tracks Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Fresh Tracks' ability to earn profits and add value for shareholders.
For Fresh Tracks profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fresh Tracks to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fresh Tracks Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fresh Tracks's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fresh Tracks Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please note, there is a significant difference between Fresh Tracks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresh Tracks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresh Tracks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Fresh Tracks Therapeutics Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Fresh Tracks's current stock value. Our valuation model uses many indicators to compare Fresh Tracks value to that of its competitors to determine the firm's financial worth.
Fresh Tracks Therapeutics is rated below average in ebitda category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fresh Tracks by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fresh Tracks' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Fresh Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Fresh Tracks

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(21.09 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Fresh Tracks

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
(4.04 M)
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Fresh Current Valuation vs Competition

Fresh Tracks Therapeutics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 817.21 Million. Fresh Tracks has negative current valuation of (4.04 Million) making no impact on the industry.

Fresh Tracks Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Fresh Tracks, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fresh Tracks will eventually generate negative long term returns. The profitability progress is the general direction of Fresh Tracks' change in net profit over the period of time. It can combine multiple indicators of Fresh Tracks, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Fresh Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Fresh Tracks. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fresh Tracks position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fresh Tracks' important profitability drivers and their relationship over time.

Use Fresh Tracks in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fresh Tracks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh Tracks will appreciate offsetting losses from the drop in the long position's value.

Fresh Tracks Pair Trading

Fresh Tracks Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Fresh Tracks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fresh Tracks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fresh Tracks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fresh Tracks Therapeutics to buy it.
The correlation of Fresh Tracks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fresh Tracks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fresh Tracks Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fresh Tracks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Fresh Tracks position

In addition to having Fresh Tracks in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run High Yield ETFs Thematic Idea Now

High Yield ETFs
High Yield ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 105 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Fresh Pink Sheet

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators